Clinical course of ulcerative colitis patients who develop acute pancreatitis

Table 4 Odds ratios for anti-tumor necrosis factor use during follow-up according to cause of acute pancreatitis, adjusted for baseline disease extent of ulcerative colitis

Cause of pancreatitis	n	OR (95%CI)	P value
No pancreatitis (reference)	3256	1.00
Autoimmune	11	0.84 (0.11-6.66)	0.873
No pancreatitis (reference)1	3256	1.00
Aminosalicylate-induced	10	5.16 (1.42-18.67)	0.012
No pancreatitis (reference)1	704	1.00
Thiopurine-induced	12	6.90 (1.83-25.98)	0.004

¹Non-pancreatitis patients (reference) who were treated with either aminosalicylates or thiopurines. Patients who had been on anti-TNF before diagnosis of pancreatitis were excluded (n = 3). UC: Ulcerative colitis.